Medpage Today on MSN21h
Over 50% of U.S. Adults Qualify for Ozempic, WegovyMore than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
Today, a brief rundown of news involving Astellas and Cytokinetics, as well as updates from Cybin, Neurogene and Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback